Company news

IM Cannabis Corp. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

IM Cannabis Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

February 7, 2022

IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel

January 18, 2022

IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary

January 12, 2022

IM Cannabis to Launch WAGNERS Brand in Germany

December 6, 2021

IM Cannabis to Acquire Oranim, Jerusalem's Leading Medical Cannabis Pharmacy

November 30, 2021

IM Cannabis Announces Focus Medical's Receipt of Israeli Ministry of Health Import Permit; Plans to Launch WAGNERS Brand in Israel

November 28, 2021

IM Cannabis Announces Fourth Installment of Shares in Connection with the Panaxia Transaction

November 17, 2021

IM Cannabis Announces Third Quarter 2021 Financial Results and Provides Outlook and Business Update

November 14, 2021

IMC Announces Third Installment of Shares in Connection with the Panaxia Transaction

October 19, 2021

IMC Provides Further Details on Panaxia Transaction

September 7, 2021

IM Cannabis Announces Q2 2021 Financial Results and Signing of Definitive Agreement to Acquire Vironna Pharm, Accelerating its Vertical Integration Strategy in Israel

August 15, 2021

IMC Partners with Leading US Brand to Launch cbdMD Products in Israel and Provides Further Details on Panaxia Transaction

August 8, 2021

IMC Announces Results of its Annual General and Special Meeting of Shareholders

August 2, 2021

IMC Accelerates its Israeli Retail Position through Acquisition of Leading Retailer and Distributor Pharm Yarok and Rosen High Way

July 27, 2021

IM Cannabis Provides Update on German Operations and Financial Outlook

July 22, 2021

IM Cannabis Provides Business, Legal and Regulatory Update

July 12, 2021

IM Cannabis Closes Acquisition of MYM Nutraceuticals

July 8, 2021

IM Cannabis Proposed Acquisition of MYM Receives Positive Recommendations from Proxy Advisory Firms Glass Lewis and ISS

June 27, 2021

IM Cannabis Clinical Survey Confirms Effectiveness of Proprietary Strains in Alleviating Symptoms of Seven Key Health Conditions

June 16, 2021

IM Cannabis Announces Supply Agreement with Canadian LP The Flowr Corporation; Plan to Import Ultra-Premium Products as part of Enhanced Portfolio to Meet Growing Israeli Demand

June 6, 2021

IMC Reports First Closing of the Panaxia Acquisition and Provides Update on Canadian Business Activities

May 31, 2021

IM Cannabis Reports Record Q1 2021 Results

May 16, 2021

IM Cannabis Announces Closing of US$ 35 Million Equity Financing

May 9, 2021

IM Cannabis Announces Proposed Public Offering of Securities

May 3, 2021

IM Cannabis Acquires Israel's Largest Retail and Online Pharmacy Business from Panaxia, Creating a Vertically Integrated Global Platform for the IMC Brand

April 29, 2021

IM Cannabis Reports Fiscal 2020 Results; Provides Preliminary Q1 Results and Q2 Outlook

April 22, 2021

IM Cannabis Provides Update on Adjupharm Business Developments in Germany

April 11, 2021

IM Cannabis to Acquire MYM Nutraceuticals and Its Licensed Producer Subsidiary, Highland Grow

March 31, 2021

IMC Announces Filing of Final Short Form Base Shelf Prospectus

March 30, 2021

IMC Closes Acquisition of Trichome, Establishing Global Growth Platform in Both Adult Use and Medical Cannabis Markets

March 17, 2021

IMC Announces Filing of Preliminary Short Form Base Shelf Prospectus

March 11, 2021

IMC to Bring Canadian Premium Indoor High-THC Medical Cannabis to Israel with Imports from GTEC

March 7, 2021

IM Cannabis Corp. Becomes First Israeli Medical Cannabis Operator to list on NASDAQ; Trading Today Under Symbol "IMCC"

February 28, 2021

← Newer news releases

Calls

The 5 newest of 14 calls. Every call is listed under its year.

Decks